STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #183 by analyst upside · 2026-06-27
VXRT
Vaxart, Inc.
Healthcare · Market Cap $123M · P/E 3.2x
ANALYST PRICE TARGET
+488.2%
implied upside to consensus target
Current Price $0.51
Consensus Target $3.0
Bull Target $4.0
Bear Target $2.0
Analysts Covering 2
ANALYST CONSENSUS — BUY
Strong Buy
0
Buy
2
Hold
0
Sell
0
52-Week Low $0.26
52-Week High $0.84
YTD Return +50.0%
FUNDAMENTALS
Market Cap $123M
P/E Ratio (TTM) 3.2x
Forward P/E -0.8x
EPS (TTM) $0.16
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $256M
Profit Margin 14.5%
52-WEEK RANGE
52-Week Low $0.26
52-Week High $0.84
Current Price $0.51
Bear Target $2.0
Bull Target $4.0
● Now $0.51 ● Target $3.0
TRADING DATA
Avg Volume 400K
YTD Return +50.0%
Analyst Count 2
Consensus Buy
Upside to Target +488.2%
Last Updated 2026-06-27

ANALYST SUMMARY

Vaxart, Inc. (VXRT) is currently trading at $0.51 with a Wall Street consensus price target of $3.0, implying potential upside of 488.2% over the next 12 months. 2 analysts currently cover VXRT, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $4.0, while the most cautious has a target of $2.0.

VXRT operates in the Healthcare sector with a market capitalisation of $123M. The stock is up 50.0% year-to-date and is currently trading near the lower end of its 52-week range of $0.26 – $0.84.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for VXRT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

B. Riley Securities — Reiterated
Buy → Buy 2025-03-27 17% win rate (6 calls)
Oppenheimer ● Initiated
Outperform 2024-08-15 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →